Erlotinib (Tarceva) During First Line Standard Platinum Containing Chemo for Advanced Squamous Cell Head and Neck Cancer
Clinical trial NCT00448240 · TERMINATED
Trial details
- NCT number
- NCT00448240
- Sponsor
- Henry Ford Health System
- Status
- TERMINATED
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2007-02-01
- Primary completion
- 2012-01-01
- Enrollment
- 6
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.